This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Stichting Sanquin Bloedvoorziening, Stichting Vrienden Van De Stichting Dr. Karl Landsteiner. Active years: 1986-2014.
Company Filing History:

Years Active: 1986-2014
Title: Dirk Roos: Innovator in Diagnostic Methods for Autoimmune Diseases
Introduction
Dirk Roos is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of diagnostics, particularly in understanding autoimmune diseases. With a total of 3 patents, his work focuses on innovative methods that enhance the prediction and treatment of these conditions.
Latest Patents
Dirk Roos's latest patents involve diagnostic methods that determine gene copy numbers and SNPs in the FcγRII/FcγRIII gene cluster. These inventions aim to predict whether a subject is predisposed to acquiring autoimmune diseases and to assess therapy responsiveness. The methods include determining the amount of intact genes or gene products from the FcγRII/FcγRIII gene cluster, which consists of several genes encoding activating and inhibitory FcγRs. This research correlates the gene amounts observed in subjects with those in a healthy population, providing valuable insights into disease susceptibility and treatment efficacy.
Career Highlights
Throughout his career, Dirk Roos has worked with prominent organizations such as Stichting Sanquin Bloedvoorziening and Stichting Vrienden Van De Stichting Dr. Karl Landsteiner. His experience in these institutions has allowed him to develop and refine his innovative diagnostic methods.
Collaborations
Dirk has collaborated with notable colleagues, including Taco Willem Kuijpers and Alwin A Voetman. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Dirk Roos stands out as an influential inventor in the field of diagnostics for autoimmune diseases. His innovative methods and collaborative efforts continue to pave the way for advancements in medical science.